Logo image of IPDN

PROFESSIONAL DIVERSITY NETWO (IPDN) Stock Fundamental Analysis

NASDAQ:IPDN - Nasdaq - US74312Y3018 - Common Stock - Currency: USD

0.235  +0 (+0.04%)

After market: 0.2014 -0.03 (-14.3%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to IPDN. IPDN was compared to 80 industry peers in the Professional Services industry. While IPDN seems to be doing ok healthwise, there are quite some concerns on its profitability. IPDN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year IPDN has reported negative net income.
In the past year IPDN has reported a negative cash flow from operations.
In the past 5 years IPDN always reported negative net income.
In the past 5 years IPDN always reported negative operating cash flow.
IPDN Yearly Net Income VS EBIT VS OCF VS FCFIPDN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

IPDN has a Return On Assets of -42.70%. This is amonst the worse of the industry: IPDN underperforms 93.75% of its industry peers.
With a Return On Equity value of -107.55%, IPDN is not doing good in the industry: 88.75% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -42.7%
ROE -107.55%
ROIC N/A
ROA(3y)-45.63%
ROA(5y)-49.07%
ROE(3y)-114.11%
ROE(5y)-124.55%
ROIC(3y)N/A
ROIC(5y)N/A
IPDN Yearly ROA, ROE, ROICIPDN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K 2K

1.3 Margins

IPDN has a better Gross Margin (61.84%) than 72.50% of its industry peers.
In the last couple of years the Gross Margin of IPDN has declined.
The Profit Margin and Operating Margin are not available for IPDN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.54%
GM growth 5Y-8.72%
IPDN Yearly Profit, Operating, Gross MarginsIPDN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

IPDN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IPDN has been increased compared to 1 year ago.
The number of shares outstanding for IPDN has been increased compared to 5 years ago.
There is no outstanding debt for IPDN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IPDN Yearly Shares OutstandingIPDN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
IPDN Yearly Total Debt VS Total AssetsIPDN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

IPDN has an Altman-Z score of -26.67. This is a bad value and indicates that IPDN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -26.67, IPDN is doing worse than 96.25% of the companies in the same industry.
There is no outstanding debt for IPDN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -26.67
ROIC/WACCN/A
WACC8.96%
IPDN Yearly LT Debt VS Equity VS FCFIPDN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M

2.3 Liquidity

IPDN has a Current Ratio of 0.45. This is a bad value and indicates that IPDN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.45, IPDN is doing worse than 96.25% of the companies in the same industry.
A Quick Ratio of 0.45 indicates that IPDN may have some problems paying its short term obligations.
IPDN has a Quick ratio of 0.45. This is amonst the worse of the industry: IPDN underperforms 96.25% of its industry peers.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.45
IPDN Yearly Current Assets VS Current LiabilitesIPDN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

IPDN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.10%, which is quite impressive.
IPDN shows a decrease in Revenue. In the last year, the revenue decreased by -9.70%.
The Revenue has been growing slightly by 0.21% on average over the past years.
EPS 1Y (TTM)60.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.94%
Revenue 1Y (TTM)-9.7%
Revenue growth 3Y19.96%
Revenue growth 5Y0.21%
Sales Q2Q%-15.65%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPDN Yearly Revenue VS EstimatesIPDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
IPDN Yearly EPS VS EstimatesIPDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IPDN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPDN Price Earnings VS Forward Price EarningsIPDN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IPDN Per share dataIPDN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IPDN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PROFESSIONAL DIVERSITY NETWO

NASDAQ:IPDN (3/7/2025, 8:00:02 PM)

After market: 0.2014 -0.03 (-14.3%)

0.235

+0 (+0.04%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)11-11 2024-11-11/bmo
Earnings (Next)03-27 2025-03-27
Inst Owners7.07%
Inst Owner Change559.51%
Ins Owners7.72%
Ins Owner Change0%
Market Cap4.28M
Analysts82.86
Price TargetN/A
Short Float %0.75%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.61
P/FCF N/A
P/OCF N/A
P/B 2.04
P/tB 18.74
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.38
BVpS0.12
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.7%
ROE -107.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.84%
FCFM N/A
ROA(3y)-45.63%
ROA(5y)-49.07%
ROE(3y)-114.11%
ROE(5y)-124.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.54%
GM growth 5Y-8.72%
F-Score5
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 31.77%
Cap/Sales 1.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.45
Quick Ratio 0.45
Altman-Z -26.67
F-Score5
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)19.85%
Cap/Depr(5y)13.08%
Cap/Sales(3y)1.54%
Cap/Sales(5y)0.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.94%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.7%
Revenue growth 3Y19.96%
Revenue growth 5Y0.21%
Sales Q2Q%-15.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y50.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.26%
OCF growth 3YN/A
OCF growth 5YN/A